Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Cell Calcium ; 22(6): 439-46, 1997 Dec.
Article in English | MEDLINE | ID: mdl-9502193

ABSTRACT

Aequorin is a bioluminescent calcium indicator consisting of a 21 kDa protein (apo-aequorin) that is covalently linked to a lipophilic cofactor (coelenterazine). The aequorin gene can be expressed in a variety of cell lines and tissues, allowing non-invasive calcium imaging of specific cell types. In the present paper, we describe the possibilities and limitations of calcium imaging with genetically introduced apo-aequorin during embryonic development. By injecting aequorin into sea urchin, Drosophila and zebrafish eggs, we found that higher aequorin concentrations are needed in smaller eggs. Our results suggest that for measuring resting levels of free cytosolic calcium, one needs aequorin concentrations of at least 40 microM in sea urchin eggs, 2 microM in Drosophila eggs, and only 0.11 microM in zebrafish eggs. A simple assay was used to determine the absolute concentrations of expressed apo-aequorin and the percentage of aequorin formation in vivo. The use of this assay is illustrated by expression of the aequorin gene in Drosophila oocytes. These oocytes form up to 1 microM apo-aequorin. In our hands, only 0.3% of this apo-aequorin combined with coelenterazine entering from the medium to form aequorin, which was not enough for calcium imaging of the oocytes, but did allow in vivo imaging of the ovaries. From these studies, we conclude that coelenterazine entry into the cell is the rate limiting step in aequorin formation. Based on the rate of coelenterazine uptake in Drosophila, we estimate that complete conversion of 1 microM apo-aequorin would take 50 days in zebrafish eggs, 2 days [corrected] in Drosophila eggs, 7 days in sea urchin eggs or 18 h in a 10 microm tissue culture cell. Our results suggest that work based on genetically introduced apo-aequorin will be most successful when large amounts of small cells can be incubated in coelenterazine. During embryonic development this would involve introducing coelenterazine into the circulatory system of late stage embryos. Calcium imaging in early stage embryos may be best done by injecting aequorin, which circumvents the slow process of coelenterazine entry.


Subject(s)
Aequorin/biosynthesis , Apoproteins/biosynthesis , Calcium-Binding Proteins/biosynthesis , Calcium/analysis , Embryonic Development , Aequorin/genetics , Aequorin/metabolism , Animals , Animals, Genetically Modified , Apoproteins/genetics , Apoproteins/metabolism , Calcium-Binding Proteins/genetics , Calcium-Binding Proteins/metabolism , Cell Size , Drosophila/embryology , Indicators and Reagents , Recombinant Proteins/biosynthesis , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Sea Urchins/embryology , Zebrafish/embryology
2.
Axone ; 13(4): 125-8, 1992 Jun.
Article in English | MEDLINE | ID: mdl-1599864

ABSTRACT

The care and treatment of patients with known increased intracranial pressure (ICP) is one of the most challenging, important and many times difficult task a neuroscience nurse faces in the critical care setting today. Advances in technology have allowed for more precise ways of measuring ICP and with these advances, nursing care has become increasingly complex requiring quick, effective decision making and a high level of expertise for the nurse caring for these patients. The research in this area remains relatively new and the unanswered questions still tend to outweigh the conclusive findings. The research has really just begun, but what research has been done provides us with useful information in helping to provide a plan of care that can be implemented with relative success. The purpose is to review the trends in the care and treatment of patients with increased ICP over the past five years and evaluate their effectiveness based on the literature reviewed. It will also provide a basic review of the relevant physiological principles of increased ICP as related to the above case and treatment.


Subject(s)
Pseudotumor Cerebri/nursing , Humans , Pseudotumor Cerebri/physiopathology , Pseudotumor Cerebri/therapy
3.
Mol Cell Biol ; 9(8): 3482-90, 1989 Aug.
Article in English | MEDLINE | ID: mdl-2477687

ABSTRACT

As in tumors with c-myc chromosomal translocations, c-myc retrovirus-induced monocyte tumors constitutively express an activated form of c-myc (the proviral gene), whereas the normal endogenous c-myc genes are transcriptionally silent. Treatment of these retrovirus-induced tumor cells with a number of bioactive chemicals and growth factors that are known to induce c-myc expression in cells of the monocyte lineage failed to induce the endogenous c-myc gene. In contrast, the same treatments induced the c-fos gene in both tumors and a control macrophage line. To investigate c-myc suppression further, a normal copy of the human c-myc gene was introduced into tumor and control cell lines by using a retrovirus with self-inactivating long terminal repeats. This transduced normal gene was expressed at equivalent levels in all cells, regardless of the state of endogenous c-myc gene expression, and was strongly induced by agents that induce the normal gene in the control cells. These results indicate that the signal transduction pathways that normally activate the c-myc gene are functional in myc-induced tumor cells and suggest that endogenous c-myc is actively suppressed. An examination of the c-myc locus itself showed that the lack of transcriptional activity correlated with the absence of several prominent DNase I-hypersensitive sites in the 5'-flanking region of the gene but without loss of general DNase sensitivity. Furthermore, analysis of 22 methylation-sensitive restriction enzyme sites in the 5'-flanking region, first exon, and first intron indicated that the silent c-myc genes remained in the same unmethylated state as did actively expressed genes. Thus, c-myc suppression does not appear to result from the most frequently described mechanisms of gene inactivation.


Subject(s)
Cell Transformation, Neoplastic/genetics , Gene Expression Regulation , Macrophages/pathology , Oncogenes , Animals , Base Sequence , Bucladesine/pharmacology , Chromatin/ultrastructure , Colony-Stimulating Factors/pharmacology , DNA/metabolism , Deoxyribonuclease I , Exons , Humans , Methylation , Mice , Molecular Sequence Data , RNA/biosynthesis , Sequence Homology, Nucleic Acid , Tetradecanoylphorbol Acetate/pharmacology , Transcription, Genetic
4.
Plant Physiol ; 82(1): 327-9, 1986 Sep.
Article in English | MEDLINE | ID: mdl-16665016

ABSTRACT

The feasibility of purifying subcellular membranes, especially plasma membranes, from oat roots using isoelectric focusing has been examined. Membranes from oat (Avena sativa L. cv Garry) root homogenates were fractionated using discontinuous sucrose density gradient centrifugation and then electrofocused using a microanalytical isoelectric focusing column. The column contained either a broad-range (pH 3-10) or narrow-range (pH 3-6) pH gradient stabilized by a 5 to 15% Ficoll gradient. Results from the broad-range columns confirmed that the isoelectric pH (pI) values of the membranes were in the acidic range, with pI values ranging from 3.9 to 5.2. Using narrow-range pH gradients, it was possible to fractionate further plasma membrane-enriched material obtained from a sucrose density gradient. We had no success at fractionating crude membrane preparations from oat roots. Narrow-range pH gradients generated by commercial ampholytes were more successful than those generated by acetate/acetic acid mixtures.

SELECTION OF CITATIONS
SEARCH DETAIL
...